Finding transcriptomics biomarkers for in vivo identification of (non-)genotoxic carcinogens using wild-type and Xpa/p53 mutant mouse models

Carcinogenesis

Volumn 30, Issue 10, 2009, Pages 1805-1812

  Jonker, Martijs J ^a   Bruning, Oskar ^a   van Iterson, Maarten ^a   Schaap, Mirjam M ^b   van der Hoeven, Tessa V ^a   Vrieling, Harry ^c   Beems, Rudolf B ^b   de Vries, Annemieke ^b   van Steeg, Harry ^b,c   Breit, Timo M ^b   Luijten, Mirjam ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; BIOLOGICAL MARKER; BIS(TRIBUTYLTIN) OXIDE; CARCINOGEN; CYCLOSPORIN A; N (2 FLUORENYL)ACETAMIDE; PROTEIN P53; XERODERMA PIGMENTOSUM GROUP A PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; BLOOD ANALYSIS; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DNA REPAIR; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC ANALYSIS; GENOTOXICITY; GENOTYPE; IN VIVO STUDY; MALE; MICROARRAY ANALYSIS; MOUSE; MOUSE MUTANT; MULTIGENE FAMILY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TOXICITY TESTING; TOXICOGENETICS; TRANSCRIPTOMICS; WILD TYPE;

ANIMALS; CARCINOGENS; DNA REPAIR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; GENOTYPE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTAGENS; RNA; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; XERODERMA PIGMENTOSUM GROUP A PROTEIN;

EID: 70349980157     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp190     Document Type: Article

References (32)

1. Lilienblum,W. et al. (2008) Alternative methods to safety studies in experimental animals: Role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH). Arch. Toxicol., 82, 211-236.
2. Gart,J.J. et al. (1986) Statistical methods in cancer research: the design and analysis of long-term animal experiments. IARC Sci. Publ., 79, 1-219.
3. Montesano,R. et al. (1986) Long-term and short-term assays for carcinogens: A critical appraisal. IARC Sci. Publ., 83, 1-564.
4. Committee on Risk Assessment Methodology, National Research Council. (1993) Issues in Risk Assessment. The National Academies Press, Washington, DC
5. Hansen,L.A. et al. (1996) Association of tumor development with increased cellular proliferation and transgene overexpression, but not c-Ha-ras mutations, in v-Ha-ras transgenic Tg.AC mice. Carcinogenesis 17, 1825-1833.
6. Tennant,R.W. et al. (2001) The Tg.AC (v-Ha-ras) transgenic mouse: nature of the model. Toxicol. Pathol., 29 (Suppl.), 51-59.
7. Flammang,T.J. et al. (1997) Neonatal mouse assay for tumorigenicity: Alternative to the chronic rodent bioassay. Regul. Toxicol. Pharmacol., 26, 230-240.
8. French,J. et al. (2001) The nature of the heterozygous Trp53 knockout model for identification of mutagenic carcinogens. Toxicol. Pathol., 29 (Suppl.), 24-29.
9. Storer,R.D. et al. (2001) P53+/- hemizygous knockout mouse: overview of available data. Toxicol. Pathol., 29 (Suppl.), 30-50.
10. Usui,T. et al. (2001) CB6F1-rasH2 mouse: Overview of available data. Toxicol. Pathol., 29 (Suppl.), 90-108.
11. de Vries,A. et al. (1995) Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA. Nature, 377, 169-173.
12. van Steeg,H. et al. (2001) DNA repair-deficient Xpa and Xpa/p53+/ -knock-out mice: Nature of the models. Toxicol. Pathol., 29 (Suppl.), 109-116.
13. van Kreijl,C.F. et al. (2001) Xpa and Xpa/p53+/- knockout mice: overview of available data. Toxicol. Pathol., 29 (Suppl.), 117-127.
14. Uehara,T. et al. (2008) A toxicogenomics approach for early assessment of potential non-genotoxic hepatocarcinogenicity of chemicals in rats. Toxicology, 250, 15-26.
15. Natsoulis,G. et al. (2008) The liver pharmacological and xenobiotic gene response repertoire. Mol. Syst. Biol., 4, 175.
16. Nie,A.Y. et al. (2006) Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity. Mol. Carcinog., 45, 914-933.
17. Fielden,M.R. et al. (2007) A gene expression biomarker provides early prediction and mechanistic assessment of hepatic tumor induction by non-genotoxic chemicals. Toxicol. Sci., 99, 90-100.
18. Ellinger-Ziegelbauer,H. et al. (2008) Prediction of a carcinogenic potential of rat hepatocarcinogens using toxicogenomics analysis of short-term in vivo studies. Mutat. Res., 637, 23-39.
19. Natsoulis,G. et al. (2005) Classification of a large microarray data set: Algorithm comparison and analysis of drug signatures. Genome Res., 15, 724-736.
20. Jacks,T. et al. (1994) Tumor spectrum analysis in p53-mutant mice. Curr. Biol., 4, 1-7.
21. de Vries,A. et al. (1997) Induction of DNA adducts and mutations in spleen, liver and lung of XPA-deficient/lacZ transgenic mice after oral treatment with benzo[a]pyrene: Correlation with tumour development. Carcinogenesis, 18, 2327-2332.
22. Wolfinger,R.D. et al. (2001) Assessing gene significance from cDNA microarray expression data via mixed models. J. Comput. Biol., 8, 625-637.
23. Kerr,M.K. et al. (2000) Analysis of variance for gene expression microarray data. J. Comput. Biol., 7, 819-837.
24. Tibshirani,R. et al. (2002) Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc. Natl Acad. Sci. USA, 99, 6567-6572.
25. Ramaswamy,S. et al. (2001) Multiclass cancer diagnosis using tumor gene expression signatures. Proc. Natl Acad. Sci. USA, 98, 15149-15154.
26. Guyon,I. et al. (2002) Gene selection for cancer classification using support vector machines. Mach. Learn., 46, 389-422.
27. Dudoit,S. et al. (2002) Comparison of discrimination methods for the classification of tumors using gene expression data. J. Am. Stat. Assoc., 97, 77-87.
28. McLachlan,G.J. et al. (2004) Analyzing Microarray Gene Expression Data. Wiley & Sons, Hoboken, NJ.
29. Cui,X. et al. (2005) Improved statistical tests for differential gene expression by shrinking variance components estimates. Biostatistics, 6, 59-75.
30. Smyth,G.K. (2005) Limma: Linear models for microarray data. In Gentleman,R., Carey,V., Dudoit,S., Irizarry,R. and Huber,W. (eds.) Bioinformatics and Computational Biology Solutions using R and Bioconductor. Springer, New York, pp. 397-420.
31. Hoogervorst,E.M. et al. (2004) p53 Heterozygosity results in an increased 2-acetylaminofluorene-induced urinary bladder but not liver tumor response in DNA repair-deficient Xpa mice. Cancer Res., 64, 5118-5126.
32. van Kesteren,P.C. et al. (2009) DNA repair-deficient Xpa/p53 knockout mice are sensitive to the non-genotoxic carcinogen cyclosporine A: Escape of initiated cells from immunosurveillance? Carcinogenesis 30, 538-543.